The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Orally Absorbed Cyclic Peptides
Abstract
Peptides and proteins are not orally bioavailable in mammals, although a few peptides are intestinally absorbed in small amounts. Polypeptides are generally too large and polar to passively diffuse through lipid membranes, while most known active transport mechanisms facilitate cell uptake of only very small peptides. Systematic evaluations of peptides with molecular weights above 500 Da are needed to identify parameters that influence oral bioavailability. Here we describe 125 cyclic peptides containing four to thirty-seven amino acids that are orally absorbed by mammals. Cyclization minimizes degradation in the gut, blood, and tissues by removing cleavable N- and C-termini and by shielding components from metabolic enzymes. Cyclization also folds peptides into bioactive conformations that determine exposure of polar atoms to solvation by water and lipids and therefore can influence oral bioavailability. Key chemical properties thought to influence oral absorption and bioavailability are analyzed, including molecular weight, octanol-water partitioning, hydrogen bond donors/acceptors, rotatable bonds, and polar surface area. The cyclic peptides violated to different degrees all of the limits traditionally considered to be important for oral bioavailability of drug-like small molecules, although fewer hydrogen bond donors and reduced flexibility generally favored oral absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999) · Journal of Combinatorial Chemistry · doi:10.1021/cc9800071 · Cited by 3,068
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
USSING, H. H., & ZERAHN, K. (1951) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1951.tb00800.x · Cited by 2,406
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Self-citationCytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Polarized monolayers formed by epithelial cells on a permeable and translucent support
Cereijido, M., Robbins, E., Dolan, W., Rotunno, C., & Sabatini, D. (1978) · The Journal of cell biology · doi:10.1083/jcb.77.3.853 · Cited by 868
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress: Miniperspective
Walensky, L. D., & Bird, G. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011675 · Cited by 795
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
Route of Passive Ion Permeation in Epithelia
FRÖMTER, E., & DIAMOND, J. (1972) · Nature New Biology · doi:10.1038/newbio235009a0 · Cited by 770
Hot spots—A review of the protein–protein interface determinant amino‐acid residues
Moreira, I. S., Fernandes, P. A., & Ramos, M. J. (2007) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21396 · Cited by 760
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681
Lown, K. S., Mayo, R. R., Leichtman, A. B., Hsiao, H.-L., Turgeon, D. K., Schmiedlin-Ren, P., Brown, M. B., Guo, W., Rossi, S. J., Benet, L. Z., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90027-8 · Cited by 680
Mannhold, R., Poda, G. I., Ostermann, C., & Tetko, I. V. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21494 · Cited by 654
Emerging Fusarium -Mycotoxins Fusaproliferin, Beauvericin, Enniatins, And Moniliformin—A Review
Jestoi, M. N. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390601062021 · Cited by 594
N-Methylation of Peptides: A New Perspective in Medicinal Chemistry
Chatterjee, J., Gilon, C., Hoffman, A., & Kessler, H. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000603 · Cited by 577
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563
Transepithelial transport in cell culture.
Misfeldt, D. S., Hamamoto, S. T., & Pitelka, D. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1212 · Cited by 502
Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., & Lokey, R. S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0563455 · Cited by 490
Wieland, T., Faulstich, H., & Fiume, L. (1978) · CRC Critical Reviews in Biochemistry · doi:10.3109/10409237809149870 · Cited by 475
Taori, K., Paul, V. J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7110064 · Cited by 428
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
A guide to Ussing chamber studies of mouse intestine
Clarke, L. L. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90649.2008 · Cited by 419
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418
Self-citationA potent cyclic hexapeptide analogue of somatostatin
Veber, D. F., Freidinger, R. M., Perlow, D. S., Paleveda, W. J., Holly, F. W., Strachan, R. G., Nutt, R. F., Arison, B. H., Homnick, C., Randall, W. C., et al. (1981) · Nature · doi:10.1038/292055a0 · Cited by 418
Rezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., & Jacobson, M. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063076p · Cited by 416
Function, structure and therapeutic potential of complement C5a receptors
Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707332 · Cited by 404
Self-citationOn-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S. F., Kalgutkar, A. S., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.664 · Cited by 386
Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., Schmid, H. A., Jelinek, R., Gilon, C., Hoffman, A., et al. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705797 · Cited by 374
Current challenges in peptide-based drug discovery
Otvos, L., & Wade, J. D. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00062 · Cited by 363
Hillgren, K. M., Keppler, D., Zur, A. A., Giacomini, K. M., Stieger, B., Cass, C. E., & Zhang, L. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.74 · Cited by 352
Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution
Loosli, H., Kessler, H., Oschkinat, H., Weber, H., Petcher, T. J., & Widmer, A. (1985) · Helvetica Chimica Acta · doi:10.1002/hlca.19850680319 · Cited by 347
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
Bird, G. H., Madani, N., Perry, A. F., Princiotto, A. M., Supko, J. G., He, X., Gavathiotis, E., Sodroski, J. G., & Walensky, L. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002713107 · Cited by 347
Designing peptide receptor agonists and antagonists
Hruby, V. J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd939 · Cited by 344
Characterization of an Established Line of Canine Kidney Cells (MDCK).
Gaush, C. R., Hard, W. L., & Smith, T. F. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-122-31293 · Cited by 338
Mechanism Matters: A Taxonomy of Cell Penetrating Peptides
Kauffman, W. B., Fuselier, T., He, J., & Wimley, W. C. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.004 · Cited by 333
ABC of oral bioavailability: transporters as gatekeepers in the gut
Dietrich, C. G., Geier, A., & Oude Elferink, R. P. J. (2003) · Gut · doi:10.1136/gut.52.12.1788 · Cited by 317
Targeting DnaN for tuberculosis therapy using novel griselimycins
Kling, A., Lukat, P., Almeida, D. V., Bauer, A., Fontaine, E., Sordello, S., Zaburannyi, N., Herrmann, J., Wenzel, S. C., König, C., et al. (2015) · Science · doi:10.1126/science.aaa4690 · Cited by 316
A novel dodecadepsipeptide, cereulide, is an emetic toxin of
AGATA, N., OHTA, M., MORI, M., & ISOBE, M. (1995) · FEMS Microbiology Letters · doi:10.1016/0378-1097(95)00119-p · Cited by 316
Structural basis of transcription: α-Amanitin–RNA polymerase II cocrystal at 2.8 Å resolution
Bushnell, D. A., Cramer, P., & Kornberg, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251664698 · Cited by 315
Development of a new permeability assay using low‐efflux MDCKII cells
Di, L., Whitney‐Pickett, C., Umland, J. P., Zhang, H., Zhang, X., Gebhard, D. F., Lai, Y., Federico, J. J., Davidson, R. E., Smith, R., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22674 · Cited by 313
The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
Clark, R. J., Jensen, J., Nevin, S. T., Callaghan, B. P., Adams, D. J., & Craik, D. J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000620 · Cited by 313
Bacteriostatic and Bactericidal Substances Produced by a Soil Actinomyces.
Waksman, S. A., & Woodruff, H. B. (1940) · Experimental Biology and Medicine · doi:10.3181/00379727-45-11768 · Cited by 311
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2012) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309
How Big Is Too Big for Cell Permeability?
Matsson, P., & Kihlberg, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00237 · Cited by 303
Cell permeability beyond the rule of 5
Matsson, P., Doak, B. C., Over, B., & Kihlberg, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.013 · Cited by 297
Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides
Qian, Z., Martyna, A., Hard, R. L., Wang, J., Appiah-Kubi, G., Coss, C., Phelps, M. A., Rossman, J. S., & Pei, D. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00226 · Cited by 296
Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs
Whitty, A., Zhong, M., Viarengo, L., Beglov, D., Hall, D. R., & Vajda, S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.005 · Cited by 285
NMR structure of cyclosporin A bound to cyclophilin in aqueous solution
Weber, C., Wider, G., Von Freyberg, B., Traber, R., Braun, W., Widmer, H., & Wuethrich, K. (1991) · Biochemistry · doi:10.1021/bi00240a029 · Cited by 267
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Brueckner, F., & Cramer, P. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1458 · Cited by 259
Drug-Permeability and Transporter Assays in Caco-2 and Mdck Cell Lines
Volpe, D. A. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.149 · Cited by 252
Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a
Finch, A. M., Wong, A. K., Paczkowski, N. J., Wadi, S. K., Craik, D. J., Fairlie, D. P., & Taylor, S. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806594 · Cited by 246
Self-citationKaplan, C. D., Larsson, K.-M., & Kornberg, R. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.023 · Cited by 246
Peptide transporters and their roles in physiological processes and drug disposition
Rubio-Aliaga, I., & Daniel, H. (2008) · Xenobiotica · doi:10.1080/00498250701875254 · Cited by 238
Hamann, M. T., & Scheuer, P. J. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00066a061 · Cited by 237
Busby, R. W., Bryant, A. P., Bartolini, W. P., Cordero, E. A., Hannig, G., Kessler, M. M., Mahajan-Miklos, S., Pierce, C. M., Solinga, R. M., Sun, L. J., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.019 · Cited by 235
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
Sugimoto, H., LeBleu, V. S., Bosukonda, D., Keck, P., Taduri, G., Bechtel, W., Okada, H., Carlson, W., Bey, P., Rusckowski, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2629 · Cited by 231
Gran, L. (1973) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1973.tb01541.x · Cited by 229
Wong, C. T. T., Rowlands, D. K., Wong, C., Lo, T. W. C., Nguyen, G. K. T., Li, H., & Tam, J. P. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201200984 · Cited by 229
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040689g · Cited by 222
Self-citationTotal Synthesis and Molecular Target of Largazole, a Histone Deacetylase Inhibitor
Ying, Y., Taori, K., Kim, H., Hong, J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8013727 · Cited by 222
X-ray structure of a decameric cyclophilin-cyclosporin crystal complex
Pflügl, G., Kallen, J., Schirmer, T., Jansonius, J. N., Zurini, M. G. M., & Walkinshaw, M. D. (1993) · Nature · doi:10.1038/361091a0 · Cited by 216
Highly active cyclic and bicyclic somatostatin analogues of reduced ring size
VEBER, D. F., HOLLY, F. W., NUTT, R. F., BERGSTRAND, S. J., BRADY, S. F., HISRSCHMANN, R., GLITZER, M. S., & SAPERSTEIN, R. (1979) · Nature · doi:10.1038/280512a0 · Cited by 213
Structural and conformational determinants of macrocycle cell permeability
Over, B., Matsson, P., Tyrchan, C., Artursson, P., Doak, B. C., Foley, M. A., Hilgendorf, C., Johnston, S. E., Lee, M. D., Lewis, R. J., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2203 · Cited by 209
Boll, M., Markovich, D., Weber, W. M., Korte, H., Daniel, H., & Murer, H. (1994) · Pflügers Archiv European Journal of Physiology · doi:10.1007/bf02584043 · Cited by 191
Suárez, Y., González, L. E., Cuadrado, A., Berciano, M., Lafarga, M., & Múñoz, A. (2003) · PubMed · Cited by 191
Fesik, S. W., Gampe, R. T., Eaton, H. L., Gemmecker, G., Olejniczak, E. T., Neri, P., Holzman, T. F., Egan, D. A., & Edalji, R. (1991) · Biochemistry · doi:10.1021/bi00240a030 · Cited by 190
Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Bockus, A. T., McEwen, C. M., & Lokey, R. S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313070005 · Cited by 187
Systematic Targeting of Protein–Protein Interactions
Modell, A. E., Blosser, S. L., & Arora, P. S. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.008 · Cited by 184
Rosenwirth, B., Billich, A., Datema, R., Donatsch, P., Hammerschmid, F., Harrison, R., Hiestand, P., Jaksche, H., Mayer, P., & Peichl, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1763 · Cited by 182
Leighton, J., Estes, L. W., Mansukhani, S., & Brada, Z. (1970) · Cancer · doi:10.1002/1097-0142(197011)26:5<1022::aid-cncr2820260509>3.0.co;2-m · Cited by 179
Clinical Pharmacokinetics: Concepts and applications.
Bryson, S. M. (1983) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1983.tb00901.x · Cited by 177
Wang, C. K., Northfield, S. E., Colless, B., Chaousis, S., Hamernig, I., Lohman, R.-J., Nielsen, D. S., Schroeder, C. I., Liras, S., Price, D. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417611111 · Cited by 171
Self-citationInfluence of Molecular Flexibility and Polar Surface Area Metrics on Oral Bioavailability in the Rat
Lu, J. J., Crimin, K., Goodwin, J. T., Crivori, P., Orrenius, C., Xing, L., Tandler, P. J., Vidmar, T. J., Amore, B. M., Wilson, A. G. E., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306529 · Cited by 169
State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Sheng, C., Dong, G., Miao, Z., Zhang, W., & Wang, W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00252d · Cited by 165
Bowers, A., West, N., Taunton, J., Schreiber, S. L., Bradner, J. E., & Williams, R. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8033763 · Cited by 165
Goetz, G. H., Philippe, L., & Shapiro, M. J. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500239m · Cited by 160
Oral Administration of Peptide‐Based Drugs: Beyond Lipinski's Rule
dos Santos, G. B., Ganesan, A., & Emery, F. D. S. (2016) · ChemMedChem · doi:10.1002/cmdc.201600288 · Cited by 159
Goh, L.-B., Spears, K. J., Yao, D., Ayrton, A., Morgan, P., Wolf, C. R., & Friedberg, T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01355-2 · Cited by 157
Cole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
A new anthelmintic cyclodepsipeptide, PF1022A.
Sasaki, T., TAKAGI, M., YAGUCHI, T., Miyadoh, S., OKADA, T., & Koyama, M. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.692 · Cited by 150
Tian, S., Li, Y., Wang, J., Zhang, J., & Hou, T. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100444g · Cited by 148
Acute oral toxicity of microcystin-LR, a cyanobacterial hepatotoxin, in mice
Yoshida, T., Makita, Y., Nagata, S., et al. (1998) · Natural Toxins · doi:10.1002/1522-7189(1997)5:3<91::aid-nt1>3.0.co;2-h · Cited by 148
Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain
de Araujo, A. D., Mobli, M., Castro, J., Harrington, A. M., Vetter, I., Dekan, Z., Muttenthaler, M., Wan, J., Lewis, R. J., King, G. F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4165 · Cited by 147
Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable
Nielsen, D. S., Hoang, H. N., Lohman, R., Hill, T. A., Lucke, A. J., Craik, D. J., Edmonds, D. J., Griffith, D. A., Rotter, C. J., Ruggeri, R. B., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405364 · Cited by 147
Self-citationBockus, A. T., Lexa, K. W., Pye, C. R., Kalgutkar, A. S. S., Gardner, J. W., Hund, K. C. R., Hewitt, W. M., Schwochert, J. A., Glassey, E., Price, D. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00128 · Cited by 147
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis
Thell, K., Hellinger, R., Sahin, E., Michenthaler, P., Gold-Binder, M., Haider, T. T., Kuttke, M., Liutkevičiūtė, Z., Göransson, U., Gründemann, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519960113 · Cited by 147
Dalisay, D. S., Rogers, E. W., Edison, A. S., & Molinski, T. F. (2009) · Journal of Natural Products · doi:10.1021/np8007649 · Cited by 143
Hopkins, S., Scorneaux, B., Huang, Z., Murray, M. G., Wring, S. A., Smitley, C., Harris, R. W., Erdmann, F., Fischer, G. S., & Ribeill, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00660-09 · Cited by 139
Fjellestad‐Paulsen, A., Höglund, P., Lundin, S., & Paulsen, O. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00990.x · Cited by 138
Crystal Structure Analysis of Deamino-Oxytocin: Conformational Flexibility and Receptor Binding
Wood, S., Tickle, I. J., Treharne, A., Pitts, J. E., Mascarenhas, Y. P., Li, J. Y., Husain, J., Cooper, S. J., Blundell, T. L., Hruby, V. J., et al. (1986) · Science · doi:10.1126/science.3008332 · Cited by 137
Acute oral toxicity of microcystin-LR, a cyanobacterial hepatotoxin, in mice
Yoshida, T., Makita, Y., Nagata, S., Tsutsumi, T., Yoshida, F., Sekijima, M., Tamura, S.-I., & Ueno, Y. (1997) · Natural Toxins · doi:10.1002/nt.1 · Cited by 137
Rand, A. C., Leung, S. S. F., Eng, H. F., Rotter, C. J., Sharma, R., Kalgutkar, A. S. S., Zhang, Y., Varma, M. V. S., Farley, K. A., Khunte, B., et al. (2012) · MedChemComm · doi:10.1039/c2md20203d · Cited by 132
Dietrich, C. G., de Waart, D. R., Ottenhoff, R., Schoots, I. G., & Elferink, R. P. J. O. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.974 · Cited by 131
SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms
Bhutia, Y. D., Babu, E., Ramachandran, S., Yang, S., Thangaraju, M., & Ganapathy, V. (2016) · Biochemical Journal · doi:10.1042/bj20150751 · Cited by 129
Cyclic peptide oral bioavailability: Lessons from the past
Wang, C. K. L., & Craik, D. J. (2016) · Biopolymers · doi:10.1002/bip.22878 · Cited by 129
Drug transport via the intestinal peptide transporter PepT1
Brandsch, M. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.004 · Cited by 119
Harder, A., Schmitt-Wrede, H.-P., Krücken, J., Marinovski, P., Wunderlich, F., Willson, J., Amliwala, K., Holden-Dye, L., & Walker, R. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00219-x · Cited by 119
Robson, W. L. M., Leung, A. K. C., & Nørgaard, J. P. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.015 · Cited by 116
Ptak, R. G., Gallay, P. A., Jochmans, D., Halestrap, A. P., Rüegg, U. T., Pallansch, L. A., Bobardt, M. D., de Béthune, M., Neyts, J. H., Clercq, E. D., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01324-07 · Cited by 115
Micro/nanofabricated platforms for oral drug delivery
Fox, C. B., Kim, J., Le, L. V., Nemeth, C. L., Chirra, H. D., & Desai, T. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.033 · Cited by 114
Ito, E., Kondo, F., & Harada, K. (2000) · Toxicon · doi:10.1016/s0041-0101(99)00084-7 · Cited by 114
Synthesis and Biological Activity of Largazole and Derivatives
Seiser, T., Kamena, F., & Cramer, N. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802043 · Cited by 113
Echinocandins in the management of invasive fungal infections, part 1
Morris, M. I., & Villmann, M. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050464.p1 · Cited by 111
Synthesis and Conformation−Activity Relationships of the Peptide Isosteres of FK228 and Largazole
Bowers, A. A., Greshock, T. J., West, N. H., Estiu, G. L., Schreiber, S. L., Wiest, O., Williams, R. M., & Bradner, J. E. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807772w · Cited by 107
Profile of alisporivir and its potential in the treatment of hepatitis C
Gallay, P. A., & Lin, L. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s30946 · Cited by 106
Fehrenbach, T., Cui, Y., Faulstich, H., & KEPPLER, D. O. R. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0814-4 · Cited by 106
Rabito, C. A., Tchao, R., Valentich, J. D., & Leighton, J. (1978) · The Journal of Membrane Biology · doi:10.1007/bf01871696 · Cited by 104
Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer
Bak, A., Leung, D., Barrett, S. E., Forster, S. P., Minnihan, E. C., Leithead, A., Cunningham, J., Toussaint, N., & Crocker, L. S. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9688-2 · Cited by 103
Namatame, I., Tomoda, H., Ishibashi, S., & Ōmura, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307757100 · Cited by 96
Ernst, B., Hoeger, S. J., O’Brien, E., & Dietrich, D. R. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2006.04.013 · Cited by 94
Melacini, G., Zhu, Q., & Goodman, M. (1997) · Biochemistry · doi:10.1021/bi962497o · Cited by 93
Enantioselective Total Synthesis of (+)-Largazole, a Potent Inhibitor of Histone Deacetylase
Ghosh, A. K., & Kulkarni, S. (2008) · Organic Letters · doi:10.1021/ol8014623 · Cited by 92
Mushrooms, amatoxins and the liver
Mas, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.003 · Cited by 91
Over, B., McCarren, P. R., Artursson, P., Foley, M. A., Giordanetto, F., Grönberg, G., Hilgendorf, C., Lee, M. D., Matsson, P., Muncipinto, G., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500059t · Cited by 90
Peptide to Peptoid Substitutions Increase Cell Permeability in Cyclic Hexapeptides
Schwochert, J. A., Turner, R. A., Thang, M., Berkeley, R. F., Ponkey, A. R., Rodriguez, K. M., Leung, S. S. F., Khunte, B., Goetz, G. H., Limberakis, C., et al. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b01162 · Cited by 87
Rademaker-Lakhai, J. M., Horenblas, S., MEINHARDT, W., Stokvis, E., de Reijke, T. M., Jimeno, J. M., Lázaro, L. L., Lopez-Martin, J. A., Beijnen, J. H., & Schellens, J. H. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1534 · Cited by 87
Hess, S., Linde, Y., Ovadia, O., Safrai, E., Shalev, D. E., Swed, A., Halbfinger, E., Lapidot, T., Winkler, I., Gabinet, Y., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701093y · Cited by 85
Wong, A. K., Finch, A. M., Pierens, G. K., Craik, D. J., Taylor, S. M., & Fairlie, D. P. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800651 · Cited by 82
Self-citationThe effect of the ionophore valinomycin on biomimetic solid supported lipid DPPTE/EPC membranes
Rose, L., & Jenkins, A. T. A. (2007) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2006.05.009 · Cited by 81
VON SAMSON-HIMMELSTJERNA, G., HARDER, A., SANGSTER, N. C., & COLES, G. C. (2005) · Parasitology · doi:10.1017/s0031182004006523 · Cited by 80
Mascio, C. T. M., Mortin, L. I., Howland, K., Praagh, A. D. G. V., Zhang, S., Arya, A., Chuong, C. L., Kang, C., Li, T., & Silverman, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00057-12 · Cited by 79
Lo, Y.-S., Tseng, W.-H., Chuang, C.-Y., & Hou, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt084 · Cited by 78
SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
Albert, R., Marbach, P., Bauer, W., Briner, U., Fricker, G., Brums, C., & Pless, J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90703-6 · Cited by 77
Intelligent substance delivery into cells using cell-penetrating peptides
Tashima, T. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.11.083 · Cited by 77
Nasveschuk, C. G., Ungermannova, D., Liu, X., & Phillips, A. J. (2008) · Organic Letters · doi:10.1021/ol8013478 · Cited by 76
Fouché, M., Schaefer, M., Berghausen, J., Desrayaud, S., Blatter, M., Piéchon, P., Dix, I., Garcia, A. M., & ROTH, H. ‐. (2016) · ChemMedChem · doi:10.1002/cmdc.201600082 · Cited by 75
Pharmacokinetics of oral cyclosporin a (Sandimmun) in healthy subjects
Grevel, J., N�esch, E., Abisch, E., & Kutz, K. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606661 · Cited by 74
Total Synthesis, Structure, and Oral Absorption of a Thiazole Cyclic Peptide, Sanguinamide A
Nielsen, D. S., Hoang, H. N., Lohman, R., Diness, F., & Fairlie, D. P. (2012) · Organic Letters · doi:10.1021/ol3027347 · Cited by 73
Self-citationRibosomal biosynthesis of the cyclic peptide toxins of Amanita mushrooms
Walton, J. D., Hallen‐Adams, H. E., & Luo, H. (2010) · Biopolymers · doi:10.1002/bip.21416 · Cited by 72
Melanocortins and body weight: a tale of two receptors
Cummings, D. E., & Schwartz, M. W. (2000) · Nature Genetics · doi:10.1038/79223 · Cited by 71
Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol
Kato, Y., Miyazaki, T., Kano, T., Sugiura, T., Kubo, Y., & Tsuji, A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21618 · Cited by 71
Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery
Hall, D. R., Kozakov, D., Whitty, A., & Vajda, S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.003 · Cited by 67
Cyclic Penta- and Hexaleucine Peptides without N -Methylation Are Orally Absorbed
Hill, T. A., Lohman, R., Hoang, H. N., Nielsen, D. S., Scully, C. C. G., Kok, W. M., Liu, L., Lucke, A. J., Stoermer, M. J., Schroeder, C. I., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5002823 · Cited by 66
Self-citationMechanisms of action of emodepside
Harder, A., Holden-Dye, L. M., Walker, R. J., & Wunderlich, F. T. (2005) · Parasitology Research · doi:10.1007/s00436-005-1438-z · Cited by 66
Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides
Nielsen, D. S., Lohman, R., Hoang, H. N., Hill, T. A., Jones, A., Lucke, A. J., & Fairlie, D. P. (2015) · ChemBioChem · doi:10.1002/cbic.201500441 · Cited by 65
Self-citationA novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan
Lee, E., Lee, J., & Jon, S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100093v · Cited by 63
Rembratt, A., Graugaard-Jensen, C., Senderovitz, T., Norgaard, J., & Djurhuus, J. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0781-9 · Cited by 62
Importance of the Cell Membrane on the Mechanism of Action of Cyclotides
Henriques, S. T., & Craik, D. J. (2012) · ACS Chemical Biology · doi:10.1021/cb200395f · Cited by 60
Oral salmon calcitonin – pharmacology in osteoporosis
Henriksen, K., Bay‐Jensen, A., Christiansen, C., & Karsdal, M. A. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.526104 · Cited by 60
Decroos, C., Clausen, D. J., Haines, B. E., Wiest, O., Williams, R. M., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00010 · Cited by 58
Fæste, C. K., Ivanova, L., & Uhlig, S. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039529 · Cited by 56
Snydman, D. R., Jacobus, N. V., & McDermott, L. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06257-11 · Cited by 52
Williams, G. H., Burrin, J. M., Ball, J. A., Joplin, G. F., & Bloom, S. R. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90300-4 · Cited by 47
Shen, Y., Luo, Q., Xu, H., Gong, F., Zhou, X., Sun, Y., Wu, X., Liu, W., Zeng, G., Tan, N., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.013 · Cited by 46
Aldrich, J. V., Senadheera, S. N., Ross, N. C., Ganno, M. L., Eans, S. O., & McLaughlin, J. P. (2013) · Journal of Natural Products · doi:10.1021/np300697k · Cited by 45
Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS
Chan, K. K., Bakhtiar, R., & Jiang, C. L. (1997) · Investigational New Drugs · doi:10.1023/a:1005847703624 · Cited by 44
Orally active-targeted drug delivery systems for proteins and peptides
Li, X., Yu, M., Fan, W., Gan, Y., Hovgaard, L., & Yang, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.924500 · Cited by 44
Taniguchi, M., Moritani, Y., Uemura, T., Shigenaga, T., Takamatsu, H., Hayashi, K., Takasaki, J., Saito, T., Nagai, K., & Kawasaki, T. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-09-0635 · Cited by 43
Alpha-fetoprotein-derived antiestrotrophic octapeptide
Mesfin, F. B., Bennett, J. A., Jacobson, H. I., et al. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00008-9 · Cited by 43
Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide
Stähelin, H., & Trippmacher, A. (1974) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(74)90137-6 · Cited by 41
Crystallographic Analysis of a Novel Complex of Actinomycin D Bound to the DNA Decamer CGATCGATCG
Robinson, H. H., Gao, Y., Yang, X., Sanishvili, R., Joachimiak, A., & Wang, A. H. ‐. (2001) · Biochemistry · doi:10.1021/bi002859z · Cited by 41
Anidulafungin: review of a new echinocandin antifungal agent
Raasch, R. H. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2.4.499 · Cited by 40
Salvador, L. A., Park, H., Al‐Awadhi, F. H., Liu, Y., Kim, B., Zeller, S. L., Chen, Q.-Y., Hong, J., & Luesch, H. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500170r · Cited by 40
Seow, V., Lim, J., Cotterell, A. J., Yau, M., Xu, W., Lohman, R., Kok, W. M., Stoermer, M. J., Sweet, M. J., Reid, R. C., et al. (2016) · Scientific Reports · doi:10.1038/srep24575 · Cited by 40
Self-citationDiscovery and development of surotomycin for the treatment of Clostridium difficile
Knight-Connoni, V., Mascio, C. T. M., Chesnel, L., & Silverman, J. A. (2015) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-015-1714-6 · Cited by 39
Role of Micafungin in the Antifungal Armamentarium
Ikeda, F., Tanaka, S., Ohki, H., Matsumoto, S., Maki, K., Katashima, M., Barrett, D. G., & Aoki, Y. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597970 · Cited by 37
Nelson‐Piercy, C., Hammond, P. J., Gwilliam, M. E., Khandan-Nia, N., Myers, M. J., Ghatei, M. A., & Bloom, S. R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.7906279 · Cited by 36
K�hler, E., Duberow-Drewe, M., Drewe, J., et al. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544562 · Cited by 35
Hovorka, S. W., Hong, J., Cleland, J. L., & Schöneich, C. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200101)90:1<47::aid-jps6>3.0.co;2-2 · Cited by 35
Jin, M., Shimada, T., Shintani, M., Yokogawa, K., Nomura, M., & Miyamoto, K. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.324 · Cited by 33
WH1fungin a surfactin cyclic lipopeptide is a novel oral immunoadjuvant
Gao, Z., Zhao, X., Lee, S., Li, J., Liao, H., Zhou, X., Wu, J., & Qi, G. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.028 · Cited by 31
Fouché, M., Schaefer, M., Blatter, M., Berghausen, J., Desrayaud, S., & ROTH, H. ‐. (2016) · ChemMedChem · doi:10.1002/cmdc.201600083 · Cited by 31
Oral absorption and in vivo biodistribution of α-conotoxin MII and a lipidic analogue
Blanchfield, J. T., Gallagher, O. P., Cros, C. D., Lewis, R. J., Alewood, P. F., & Tóth, I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.138 · Cited by 26
Lewis, I., Schaefer, M., Wagner, T., Oberer, L., Sager, E., Wipfli, P., & Vorherr, T. E. (2014) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-014-9447-3 · Cited by 22
Pinto, M. F. S., de Almeida, R. G., Porto, W. F., Fensterseifer, I. C. M., de Lima, L. A., Dias, S. C., & Franco, O. L. (2011) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587211428077 · Cited by 22
Solution, solid phase and computational structures of apicidin and its backbone‐reduced analogs
Kranz, M., Murray, P. J., Taylor, S., Upton, R. J., Clegg, W., & Elsegood, M. R. J. (2005) · Journal of Peptide Science · doi:10.1002/psc.738 · Cited by 21
Largazole Pharmacokinetics in Rats by LC-MS/MS
Yu, M., Salvador, L. A., Sy, S. K. B., Tang, Y., Singh, R. S. P., Chen, Q.-Y., Liu, Y., Hong, J., Derendorf, H., & Luesch, H. (2014) · Marine Drugs · doi:10.3390/md12031623 · Cited by 17
Structure-Activity Relationship of Anthelmintic Cyclooctadepsipeptides
Ohyama, M., OKADA, Y., Takahashi, M., Sakanaka, O., Matsumoto, M., & Atsumi, K. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110129 · Cited by 16
Cunningham, T. J., Greenstein, J. I., Loewenstern, J., Degermentzidis, E., & Yao, L. (2014) · Rejuvenation Research · doi:10.1089/rej.2014.1620 · Cited by 16
Kachi, S., Ishih, A., & Terada, M. (1995) · Parasitology Research · doi:10.1007/bf00931838 · Cited by 15
Preformulation Studies with Melanotan-II: A Potential Skin Cancer Chemopreventive Peptide
Lan, E.-L., Ugwu, S. O., Blanchard, J. D., Fang, X., Hruby, V. J., & Sharma, S. D. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830805 · Cited by 14
Hurevich, M., Swed, A., Joubran, S., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.053 · Cited by 13
Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis
Adachi, Y., Enomoto, M., Adachi, M., Suwa, M., Nagamine, Y., Nanno, T., Hashimoto, T., Inoue, H., & Yamamoto, T. (1982) · Gastroenterologia Japonica · doi:10.1007/bf02779133 · Cited by 12
Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats
Shin, B. S., Chang, H. S., Park, E. H., Yoon, C. H., Kim, H. Y., Kim, J., Ryu, J. K., Zee, O. P., Lee, K. C., Cao, D., et al. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.485 · Cited by 8
Cunningham, T. J., Greenstein, J. I., & Yao, L. (2009) · The Open Enzyme Inhibition Journal · doi:10.2174/1874940200902010001 · Cited by 6
Kicielińska, J., Szczygieł, A., Rossowska, J., Anger, N., Kempińska, K., Świtalska, M., Kaszowska, M., Wietrzyk, J., Boratyński, J., & Pajtasz‐Piasecka, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148156 · Cited by 6
Cited by
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848
Advances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Metadata
- Authors
- Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-05-25
- Volume
- 117
- Issue
- 12
- Pages
- 8094-8128
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2618351167
- Cited by
- 445
- References
- 196
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.